Pay Up

British Drug Maker Fined $750M

Ouch! British pharmaceutical company GlaxoSmithKline has agreed to pay $750 million in fines after being outed for unsafe practices at one of its manufacturing plants. The company, which produces popular drugs like the anti-depressant Paxil, admitted that a plant in Puerto Rico allowed several of its products to become contaminated—though no patients were said to be harmed as a result. The fine is great news for Cheryl Eckard, a former quality assurance manager with Glaxo who was fired after reporting the problem to the FDA in 2003; she’ll get $96 million from the settlement.